| |
A20E10 (n = 48)
|
A40 (n = 50)
|
P value
|
|---|
|
Age(yrs)
|
56 ± 11
|
57 ± 8
|
0.6014
|
|
Male/Female
|
35/13
|
36/14
|
0.8207
|
|
TC(mmol/L)
|
4.91 ± 0.95
|
4.82 ± 0.73
|
0.645
|
|
TG(mmol/L)
|
1.89 ± 0.73
|
1.74 ± 0.79
|
0.332
|
|
HDL-C(mmol/L)
|
1.07 ± 0.25
|
1.14 ± 0.31
|
0.195
|
|
LDL-C(mmol/L)
|
3.31 ± 0.89
|
3.20 ± 0.90
|
0.540
|
|
Non-HDL-C(mmol/L)
|
3.91 ± 0.91
|
3.56 ± 0.78
|
0.077
|
|
Lp(a) (mg/L)
|
222 ± 215
|
160 ± 195
|
0.140
|
|
ApoB(mmol/L)
|
1.09 ± 0.29
|
1.10 ± 0.26
|
0.774
|
|
Apa A1(mmol/L)
|
1.30 ± 0.33
|
1.45 ± 0.45
|
0.063
|
|
ALT(U/L)
|
23.44 ± 15.36
|
19.90 ± 10.84
|
0.190
|
|
AST(U/L)
|
19.89 ± 5.99
|
17.80 ± 6.02
|
0.089
|
|
TBil(umol/L)
|
14.26 ± 4.19
|
13.96 ± 4.28
|
0.722
|
|
DBil(umol/L)
|
2.30 ± 0.64
|
2.34 ± 0.71
|
0.748
|
|
Cr(umol/L)
|
77.69 ± 15.57
|
73.36 ± 14.79
|
0.163
|
|
BUN(mmol/L)
|
5.05 ± 1.07
|
5.28 ± 1.16
|
0.327
|
|
CK(U/L)
|
82.13 ± 35.11
|
107.60 ± 117.44
|
0.157
|
|
FBG(mmol/L)
|
5.34 ± 1.00
|
5.76 ± 1.24
|
0.075
|
|
HsCRP(mg/dL)
|
1.74 ± 1.97
|
2.45 ± 3.00
|
0.178
|
|
ox-LDL(U/L)
|
6.04 ± 2.00
|
6.04 ± 2.00
|
0.998
|
- Notes: TC Total cholesterol, TG Triglyceride, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, Lp(a) Lipoprotein a, ApoB Apolipoprotein B, ApoAI ApolipoproteinAI, ALT Alanine aminotransferase, AST Aspartate Transaminase, TBil Total Bilirubin, DBil Direct Bilirubin, Cr Creatinine, CK Creatine Kinase, UA Uric Acid, FBG Fasting Blood Glucose, HsCRP High sensitive C- Reactive Protein, ox-LDL oxidation low-density lipoprotein
- A20E10 indicates the patients who received Atorvastatin 20 mg qn plus Ezetimibe 10 mg qd,A40 indicates the patients who received Atorvastatin 40 mg qn
